PMID: 6164883May 9, 1981Paper

Application of human leucocyte interferon in patients with urinary bladder papillomatosis, breast cancer, and melanoma

Lancet
D IkićE Soos

Abstract

Eight patients with malignant papillomaosis of the bladder, four with breast cancer, and two with malignant melanoma, all of whom had a poor prognosis, were treated with injection of crude human leucocyte interferon (HLI) into the tumour or the adjacent tissue and in some cases with intramuscular HLI injection also. All tumours showed complete or partial regression after treatment for up to 6 months. One patient with breast cancer died from distant metastases; all other patients in the trial were recurrence-free after 3--30 months of follow-up.

Citations

Mar 13, 2013·American Journal of Clinical Dermatology·Elizabeth A Quigley, Allan C Halpern
Jan 1, 1982·Journal of Interferon Research·C H ScorticattiR Comolli
Jan 1, 1983·Journal of Interferon Research·M E Davies, A K Field
Dec 1, 1995·International Journal of Dermatology·D IkićP Nola
Nov 1, 1996·Seminars in Urologic Oncology·B J GitlitzR A Figlin
Aug 1, 1992·British Journal of Urology·R MigliariE Usai
May 23, 1998·The Journal of Urology·A S BelldegrunR D Williams
Sep 24, 1982·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·G M Scott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.